News: Spotlight on Congress
The nation’s four major airlines and their trade organization have spent more than $350 million on lobbying federal officials since their last bailout -- the equivalent of more than $650,000 for every House and Senate member.
A measure to lower drug prices narrowly passed the House last month, despite a near-even split of pharmaceutical industry money among Republican lawmakers, who almost unanimously opposed the bill, and Democrats, who unanimously supported it.
Opponents of a bill to give the EPA more power over hazardous "forever chemicals" received 20 percent more in campaign contributions from the chemicals’ manufacturers than supporters.
Hospital, drug, and insurance companies battling plans that would cut into their profits by providing health care for all Americans are spending money like it's 2008 again -- and using the same playbook to frame the debate.
Facebook, Amazon, Apple, and Alphabet have spent more than $330 million on attempts to influence federal lawmakers since 2008
Health-care and fossil fuel industry lobbyists raised almost $1.5 million for the DSCC during the first six months of the year.
An amicus brief calling on the Supreme Court to drop its review of New York City’s gun control rules points to a report from MapLight and the Center for Responsive Politics about the Judicial Crisis Network (JCN), a dark money organization which spent millions to ensure Justice Brett Kavanaugh’s confirmation.
The Darkest Money In Washington: Business Groups Spend More On Advocacy And Consulting Than Lobbying
Influential corporate trade organizations and nonprofits spent $535 million on lobbying in 2017 and as much as another $675 million on unregulated efforts to influence public policy.
An executive order banning U.S. companies from dealing with Chinese telecom giant Huawei Technologies spurred the company and its U.S. suppliers to boost their lobbying expenditures by more than 20 percent during the first half of the year.
The five incumbent House Democrats who cosponsored Obamacare but who have declined to endorse Medicare-for-All have received an average of $209,000 since 2011 from the 10 largest U.S. health-care companies and five major trade associations.